ChiroBlock GmbH

ChiroBlock GmbH is a specialized chemical contract research organization (cCRO) based in Wolfen, Germany, founded in 1999. The company focuses exclusively on the synthesis of complex, non-commercial, and highly sophisticated molecules for research and development teams in industries including pharmaceuticals, biotechnology, and materials science. Its services range from the first-time synthesis of novel compounds and reference standards to route scouting, process optimization, and custom synthesis at scales from milligrams to kilograms. ChiroBlock utilizes a variety of advanced chemical technologies and operates under strict quality management, maintaining ISO 9001 certification and emphasizing full intellectual property protection and confidentiality.

By serving as a dedicated synthesis partner, ChiroBlock allows R&D organizations to outsource highly technical chemical development tasks, enabling them to reduce development timelines and minimize technical risks. The company operates on a service-based business model that excludes catalog sales or commercial production, ensuring a neutral position focused solely on solving complex synthetic challenges. Their expertise is supported by a highly qualified team, with a majority holding PhDs in chemistry, and a track record of over 100,000 successful synthesis projects. This approach provides customers with robust, reproducible synthetic routes and specialized chemicals essential for early-stage innovation and sensitive development phases.